Delivery Order SPE2DB22D3401-SPE2DB25FT4MA

Award Date 6/10/25
Potential Completion Date 6/11/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PREMARIN 0.3 MG TABLET 1000S. The fixed-price contract has a ceiling value of $29,708.01 and a performance period ending on May 14, 2025. It is not a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,354.77, is for the supply of PREMARIN 0.3 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of June 14, 2024 and is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PREMARIN 1.25 MG TABLET 100S, a pharmaceutical product, with a ceiling value of $4,918.29 and a performance period through August 29, 2024. The contract is a Firm Fixed Price, non-set-aside vehicle, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $26,139.00 firm fixed-price contract is for the delivery of Premarin 0.3 mg tablets. The contract has an ultimate completion date of April 3, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,659.01 firm fixed-price contract is for the delivery of PREMARIN 0.3 MG TABLET 100S, a type of hormone treatment medication. The contract has an ultimate completion date of May 21, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Premarin 0.3 mg tablets. The contract has a ceiling value of $2,019.10 and is a firm fixed-price delivery order with an ultimate completion date of April 18, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Premarin 1.25 mg tablets. The contract has a ceiling value of $1,958.86 and runs through August 7, 2024. It is a firm-fixed-price contract with no set-aside designation. AmerisourceBergen, through its extensive supply chain network, will provide these prescription medication tablets to support the healthcare...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PREMARIN 0.3 MG TABLET 100S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $3,179.58 and a performance period ending on May 30, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PREMARIN 0.625 MG TABLET 100S, a pharmaceutical product, with a ceiling value of $1,159.95 and a period of performance through July 29, 2024. The contract is a firm fixed-price delivery order, and there is no set-aside designation indicated. AmerisourceBergen holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PREMARIN 0.625 MG TABLET 100S, a pharmaceutical product, with a ceiling value of $2,052.86 and a completion date of May 20, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition....
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB25FT4MA
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PREMARIN 0.3 mg tablets. The contract has a firm fixed-price, with a ceiling value of $1,552.53 and a completion date of June 11, 2025. This contract is not set aside and represents open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 9/9/25, 12:49 PM